ValGenesis
ValConnect 2024 Sessions
See All 2024 Sessions

How Generative AI May Impact the Validation of Computerized Systems

Sathish Kumar Shanmugam

Global VP of Customer Advocate

ValGenesis

Profile

Dig into the frontier of generative AI and its potential within validation processes. Includes a discussion on agile validation, machine learning, the benefits of generative AI within automated testing, and primary validation use cases.


More About Artificial Intelligence (AI)

Reevaluating Paper-Based CQV: Why Clinging to Tradition Increases Risk

Learn how digital equipment qualification in the pharmaceutical industry reduces risk and accelerates product release by replacing paper-based CQV processes.

ValConnect Innovation Day Princeton: A Glimpse into the Digital Future of Life Sciences

ValConnect Innovation Day Princeton brought Bayer, GSK, Cardinal Health, Transcat & Hansa Biopharma together to explore AI & Smart GxP™ in life sciences.

Audit Pressure? Stop Last-Minute Scrambles  With AI-Powered CQV

Discover how adopting a risk-based, AI-powered approach to CQV can streamline audit readiness, reduce stress, and ensure compliance in pharmaceutical manufacturing.

Ready to Learn More? Request a Demo of VLMS

ValGenesis delivers integrated and smart solutions that support the digital transformation of the life sciences industry. With a portfolio that covers the whole product lifecycle, ValGenesis has a digital or technical solution that brings value to each step of your validation and manufacturing processes and their related activities.

  • Blog
  • Careers
  • Contact Us
  • About ValGenesis

 

© 2025 ValGenesis, Inc. All rights reserved. | Privacy Policy

All registered marks in this website are registered trademarks of ValGenesis Inc. USA and its affiliated companies.